Search results for

NPR's Scott Simon talks to Gillian Tett, a columnist at the Financial Times, about the global economic fallout from President Trump's tariff policies.

Jason Reynolds writes young adult books that don't talk down to kids. His newest audio-only book is called Soundtrack. He talks with Rachel Martin about writing and the value of being a crier.

NPR's Juana Summers talks with Harvard Kennedy School of Government political scientist Erica Chenoweth about whether protests like those against President Trump change minds or policies.

The reason why birds make such a racket at dawn is still unclear. But researchers are now pouring cold water on one popular idea about why.

French violinist and social media influencer Esther Abrami releases her new album, Women, featuring music by female composers in a bid to redress historic biases.

Ocean Vuong's sweeping new novel centers on a depressed 19-year-old college dropout who becomes the caregiver to a widow with dementia.

6/19/24 On the Arts Host David Latulippe welcomes guests Linda Perry & Don Hardy with their documentary "Linda Perry: Let It Die Here"; Baritone Joseph Lattanzi; Artistic Director Carrie-Ann Matheson and KALW's own Sarah Cahill. Wednesdays @ 4:00PM!

The Republican proposal would eliminate grad PLUS loans, set strict limits on parent PLUS loans and create a system in which colleges would be on the hook if their students don't repay their loans.

Bay Area ambassador E-40 packs in three decades' worth of hits at the Tiny Desk for Black Music Month.

NPR's Juana Summers talks with New York Rep. Mike Lawler, a republican, about the Senate's tax and spending bill – and whether he thinks the House has enough votes to send it to the president's desk.

NPR's Michel Martin speaks with Elliot Williams, legal analyst and former Justice Department deputy assistant attorney general, about the Trump administration's response to court orders.

Purdue Pharma and Sackler family members who own the company have reached a $7.4 billion settlement with all 50 states and U.S. territories over the company's improper marketing of opioids.